Nuclear Signaling Pathways and Targeting Transcription in Cancer /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Humana,
2014.
|
| Edición: | 1st ed. 2014. |
| Colección: | Cancer Drug Discovery and Development,
|
| Materias: |
Tabla de Contenidos:
- Preface
- Steroid Receptor Coactivators (SRCs) as Integrators of Multiple Signaling Pathways in Cancer Progression
- Role of Alteration/Deficiency in Activation (ADA) Complex in the Cell Cycle, Genomic Instability and Cancer
- RUNX2 Transcriptional Regulation in Development and Disease
- Epigenetic Mechanisms of Cancer Metastasis
- Regulatory Effects of Arsenic on Cellular Signaling Pathways: Biological Effects and Therapeutic Implications
- Nuclear Factors Linking Cancer and Inflammation
- Regulation of the Jak/STATs Pathways by Histone Deacetylases
- Receptor Tyrosine Kinases in the Nucleus: Nuclear Functions and Therapeutic Implications in Cancers
- Nucleolar Signaling Determines Cell Fate – The RP-Mdm2-p53 Axis Fine-Tunes Cellular Homeostasis
- Transcriptional Regulation of Lipogenesis as a Therapeutic Target for Cancer Treatment
- Selective Inhibition of Acetyl-Lysine Effector Domains of the Bromodomain Family in Oncology
- Domain Specific Targeting of Cancer
- The Potential of Targeting Splicing for Cancer Therapy
- Exploiting Cell Cycle Pathways in Cancer Therapy: New (and Old) Targets and Potential Strategies
- Histone Demethylases in Prostate Cancer
- Therapeutic Significance of Chromatin Remodeling Complexes in Cancer
- Index.